Home / yoga / FREE Printables Library
FREE Printables Library

FREE Printables Library

FREE Resource Library login | Grounded Panda

Yoga as an integrated form of exercise, according to epidemiological studies, can have a significant and positive effect in relieving symptoms and treating irritable bowel syndrome (IBS).

Irritable bowel syndrome (IBS) is a disease affecting the large intestine. These include symptoms such as cramping, abdominal pain, bloating, bloating and diarrhea or constipation.

Yoga, the age-old technique for harmonizing the physical and external well-being of the body through breath control, meditation, body movements and gestures, is well known to people in the Western world and some parts of Asia for its health benefits reported by various respected institutions. Research and supported by health lawyers ,

In a randomized, controlled trial comparing the effectiveness of yoga with the usual treatment of patients with IBS, non-pharmacological or pharmacological interventions were reviewed using literature available in databases from MEDLINE / PubMed, Scopus, the Cochrane Library, CAM-QUEST, CAMbase and IndMED was published After selected studies met the criteria and guidelines, researchers submitted the following results by November 2015

1. Yoga participants expressed a significant positive effect over conventional treatment for IBS.

2. Yoga interventions showed significantly reduced bowel symptoms, IBS severity and anxiety.

3. The yoga group showed improved quality of life and physical performance compared to other treatment groups.

4. The yoga group also showed little or no adverse effects in the selected studies

Dr. Schumann D., the lead authors, said, "The results of this systematic review suggest that yoga may be a viable and safe adjunctive treatment for people with IBS." However, considering the other founders, "because of serious deficiencies in the research methods, no recommendation for yoga could be made as a routine intervention for patients with IBS."

Further analysis of the study involving a total of 51 participants of adolescents (14-17 years) who were randomly assigned to a standardized 6-week, twice-weekly Iyengar yoga group program or to a standard care waiting list control group run by The University of California conducted scientists submitted the results as follows

1. The yoga group showed a significant improvement in physical performance

2. Compared to control, yoga participants reported significantly improved IBS symptoms, global improvement, disability, psychological distress, sleep quality, and fatigue

3. 46% of YA reported a minimal clinically significant pain reduction

4. At the end of the intervention, Postelson's YA group also reported a reduction in the worst pain, constipation and nausea.

Taking into account other confounding factors, dr. Evans S., the lead author, said, "The findings suggest that a brief intervention in young people with IBS is a viable and safe adjunctive treatment that results in a range of IBS-specific benefits and well-functioning areas for YA" and " Yoga interventions can be most fruitful if they are tailored to development. "

Further examining illustration of 35 adult participants who met the ROME III criteria for IBS-controlled patients, 27 of the 35 participants (77%) completed the treatment and pre-and post-treatment visits (89% women, 11% men; SD) age = 36) (13)) and 20 of the 27 (74%) randomly assigned to 16 bi-weekly group sessions with Iyengar yoga or a walking program and 6-month follow-up found that :

1. The yoga group showed an improvement over the control group before the post-treatment

2. The yoga group showed a significant reduction in the severity of IBS, visceral sensitivity, and severity of somatic symptoms compared to the group from before to after treatment.

After 6 months of follow-up, the researcher said, "The overall GI symptoms of walking continued to decrease significantly, while the GI symptoms in yoga fell back to baseline levels."

The results suggest that yoga can be used as an adjunct to support standard therapy for the treatment of irritable bowel syndrome (IBS).